Dashboard
Manage Tickers

ARMP


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

armata-pharmaceuticals-to-present-late-breaking-phase-2a-data-for-ap-sa02-bacteriophage-cocktail-in-complicated-staphylococcus-aureus-bacteremia-at-idweek-2025-in-atlanta-on-oct-22
Armata Pharmaceuticals To Present Late-Bre...
10/14/2025 11:10:32

armata-pharmaceuticals-advances-cystic-fibrosis-infection-treatment-with-phage-research
Armata Pharmaceuticals Advances Cystic Fib...
09/08/2025 11:11:36

Armata Pharmaceuticals, Inc. (NYSE:ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company fo...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
09/03/2025 21:06:23

armata-pharmaceuticals-files-for-mixed-shelf-of-up-to-100m
Armata Pharmaceuticals Files For Mixed She...
08/13/2025 21:20:36

https://www.sec.gov/Archives/edgar/data/921114/000110465925077648/tm2523066d1_s3.htm

armata-pharmaceuticals-q2-eps-045-misses-039-estimate-sales-2169m-beat-1380m-estimate
Armata Pharmaceuticals Q2 EPS $(0.45) Miss...
08/12/2025 20:32:36

Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate o...

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
05/19/2025 21:05:52

hc-wainwright--co-maintains-buy-on-armata-pharmaceuticals-raises-price-target-to-9
HC Wainwright & Co. Maintains Buy on Armat...
05/19/2025 17:50:05

HC Wainwright & Co. analyst Joseph Pantginis maintains Armata Pharmaceuticals (AMEX:ARMP) with a Buy and raises the pric...

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
05/19/2025 12:09:34

armata-pharmaceuticals-announced-positive-topline-results-from-its-phase-1b2a-disarm-trial-which-evaluated-ap-sa02-a-novel-intravenous-administered-multi-phage-therapeutic-for-the-treatment-of-staphylococcus-aureus-bacteremia-in-the-intent-to-treat-population
Armata Pharmaceuticals Announced Positive ...
05/19/2025 11:04:47

armata-pharmaceuticals-q1-eps-020-beats-038-estimate-sales-49100k-miss-138m-estimate
Armata Pharmaceuticals Q1 EPS $(0.20) Beat...
05/14/2025 20:23:45

Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of ...

armata-secures-465m-dod-funding-to-advance-ap-sa02-trial-for-staph-bacteremia-topline-data-expected-q2-2025
Armata Secures $4.65M DoD Funding To Advan...
05/01/2025 11:46:31

armata-pharmaceuticals-q4-2024-gaap-eps-023-beats-035-estimate-sales-124m-miss-156m-estimate
Armata Pharmaceuticals Q4 2024 GAAP EPS $(...
03/20/2025 22:00:10

Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of ...

armata-enters-10m-secured-credit-agreement-with-innoviva-strategic-opportunities-llc
Armata Enters $10M Secured Credit Agreemen...
03/12/2025 21:10:20

The gross proceeds to be received by the Company at closing are $10 million before deducting transaction-related expenses.

hc-wainwright--co-reiterates-buy-on-armata-pharmaceuticals-maintains-7-price-target
HC Wainwright & Co. Reiterates Buy on Arma...
12/19/2024 16:47:04

HC Wainwright & Co. analyst Joseph Pantginis reiterates Armata Pharmaceuticals (AMEX:ARMP) with a Buy and maintains $7 p...

armata-pharmaceuticals-announced-topline-results-from-its-phase-2-tailwind-trial-of-ap-pa02-for-chronic-pulmonary-pseudomonas-aeruginosa-infections-in-non-cystic-fibrosis-bronchiectasis-patients
Armata Pharmaceuticals Announced Topline R...
12/19/2024 12:19:39

Results demonstrate that inhaled AP-PA02 provides a durable reduction of Pseudomonas aeruginosa in the lung, with a favorable s...

hc-wainwright--co-reiterates-buy-on-armata-pharmaceuticals-maintains-7-price-target
HC Wainwright & Co. Reiterates Buy on Arma...
11/14/2024 18:16:01

HC Wainwright & Co. analyst Joseph Pantginis reiterates Armata Pharmaceuticals (AMEX:ARMP) with a Buy and maintains $7 p...

armata-pharmaceuticals-q3-eps-015-beats-028-estimate-sales-297m-beat-90000k-estimate
Armata Pharmaceuticals Q3 EPS $(0.15) Beat...
11/13/2024 21:31:41

Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of ...

hc-wainwright--co-reiterates-buy-on-armata-pharmaceuticals-maintains-7-price-target
HC Wainwright & Co. Reiterates Buy on Arma...
11/12/2024 16:00:12

HC Wainwright & Co. analyst Joseph Pantginis reiterates Armata Pharmaceuticals (AMEX:ARMP) with a Buy and maintains $7 p...

armata-pharmaceuticals-has-achieved-full-enrollment-n50-of-its-phase-1b2a-disarm-study-of-intravenous-ap-sa02-for-staphylococcus-aureus-bacteremia-topline-data-is-expected-in-the-first-quarter-of-2025
Armata Pharmaceuticals Has Achieved Full E...
11/12/2024 12:14:35

armata-pharmaceuticals--appoints-david-house-as-svp-of-finance-and-principal-financial-officer
Armata Pharmaceuticals Appoints David Hou...
08/15/2024 20:46:39

Armata Pharmaceuticals, Inc. (NYSE:ARMP) ("Armata" or the "Company"), a biotechnology company focused on the de...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION